Natural remedy: Consumer demand for biologic drugs will stimulate industry revenue growth

Over the past five years, the Brand Name Pharmaceutical Manufacturing industry in the United States experienced several new drug launches, with 42 new active substances (NAS) launched in 2017 alone. According to research by IQVIA, the number of new drug launches in 2017 was more than double the number launched in the prior year, with many new drug launches focusing on rare diseases and oncology. Given increasing price scrutiny and competition from generics, as well as intensifying market competition among brand name producers and rising research and development (R&D) expenses, many manufacturers shifted their strategic focus from blockbuster drugs to more lucrative therapy areas, such as rare diseases and oncology...purchase to read more.

Industry Statistics & Market Size
Revenue
$172bn
Annual Growth 13-18
3.6%
Forecast Growth 18-23
Profit
Employment
195,513
Businesses
3,530

Industry Threats & Opportunities

  • Many manufacturers shifted their strategic focus from blockbuster drugs to more lucrative therapy areas
  • The industry landscape has been prone to competition from generic drug manufacturers
  • Manufacturers will likely continue to heavily invest in the R&D of orphan drugs
  • Industry Report - Industry Analysis Chapter

    Over the five years to 2018, revenue for the Brand Name Pharmaceutical Manufacturing industry is expected to grow an annualized 3.6% to $171.7 billion, with revenue expected to increase 0.1% in 2018 alone. Overall, total spending on pharmaceuticals grew due to increased access to insurance and rising total health expenditure, which IBISWorld expects to rise an annualized 3.5% during the five-year period. However, despite strong revenue performance, industry operators contended with a changing competitive landscape due to mounting competition from lower-cost generic drugs, biosimilars and the patent expirations of several blockbuster drugs. In addition, operators dealt with increasing research and development (R&D) costs and intensifying price scrutiny. As ...purchase to read more.

    Additional Insights for the Brand Name Pharmaceutical Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Brand Name Pharmaceutical Manufacturing Industry are

  • Establishment of brand names
  • Undertaking pharmaceutical and medicine R&D
  • Degree of globalization in the company
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Median age of population in the Brand Name Pharmaceutical Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Brand Name Pharmaceutical Manufacturing Industry?

    Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.

    Industry Products
  • Mental health and nervous system prescriptions
  • Antihypertensives and lipid regulator prescriptions
  • Pain and antibacterial prescriptions
  • Respiratory prescriptions
  • Antidiabetes prescriptions
  • Dermatological prescriptions
  • Industry Activities
  • Pharmaceutical research and development
  • Manufacturing active ingredients used in pharmaceuticals
  • Manufacturing chemical pharmaceutical preparations
  • Manufacturing biological pharmaceutical products
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Median age of population
  • Number of people with private health insurance
  • Regulation for the Brand Name Pharmaceutical Manufacturing industry
  • Research and development expenditure
  • Trade-weighted index

  • Current Performance
  • Diversifying drug pipelines
  • Industry structure
  • Regulation and trade
  • Chart: Revenue Growth

  • Industry Outlook
  • Orphan drugs and specialty therapies
  • Drug pipelines
  • International trade
  • Table: Brand Name Pharmaceutical Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Brand Name Pharmaceutical Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Navigational Instrument Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Other
  • Antihypertensives and lipid regulator prescriptions
  • Mental health and nervous system prescriptions
  • Pain and antibacterial prescriptions
  • Antidiabetes prescriptions
  • Respiratory prescriptions
  • Dermatological prescriptions
  • Chart: Brand Name Pharmaceutical Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Insurance providers
  • Population demographics
  • Marketing

  • Major Markets
  • Chain stores
  • Exports
  • Mail service providers
  • Clinics
  • Independent retailers
  • Nonfederal hospitals
  • Food stores
  • Other
  • Chart: Major Market Segmentation for the Brand Name Pharmaceutical Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Research and development
  • Depreciation and wages
  • Marketing and rent and utilities
  • Chart: Cost Structure Benchmarking – Sector vs Brand Name Pharmaceutical Manufacturing

  • Basis of Competition
  • Internal competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Brand Name Pharmaceutical Manufacturing Industry

  • Industry Globalization
    Johnson & Johnson, AbbVie Inc., Amgen Inc., Merck & Company Inc., Pfizer Inc., Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company,
  • Table: Johnson & Johnson - financial performance
  • Table: AbbVie Inc. - financial performance
  • Table: Amgen Inc. - financial performance
  • Table: Merck & Company Inc. - financial performance
  • Table: Pfizer Inc. - financial performance
  • Table: Sanofi S.A. - financial performance
  • Table: Bristol-Myers Squibb - financial performance
  • Table: Eli Lilly and Company - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Brand Name Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Brand Name Pharmaceutical Manufacturing Industry
    Includes:
  • Industry Revenue (2009-2023)
  • Industry Gross Product (2009-2023)
  • Establishments (2009-2023)
  • Businesses (2009-2023)
  • Employment (2009-2023)
  • Exports (2009-2023)
  • Imports (2009-2023)
  • Wages (2009-2023)
  • Total health expenditure (2009-2023)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Table: Industry Financial Ratios
    Biologic
  • A drug made from large-molecule living matter, as opposed to small-molecule chemicals.
  • Biosimilar
  • A drug derived from living organisms and marketed after the patent expiration of similar therapies. Also known as flow-on biologics or biogenerics.
  • Blockbuster Drug
  • A drug that generates annual sales of more than $1.0 billion.
  • Orphan Drug
  • A pharmaceutical or medicine designed to treat certain rare diseases.
  • Outsource
  • To procure goods or services under contract with an outside supplier.
  • Over-The-Counter (Otc) Drugs
  • Medicines that may be sold directly to a consumer without a prescription from a healthcare professional.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • Review
  • The basis of the FDA's decision to approve an application. It is a comprehensive analysis of clinical trial data and other information prepared by FDA drug application reviewers.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s industry research report on Brand Name Pharmaceutical Manufacturing contains five-year forecasts and data analysis that can help you identify and mitigate risks in potential new markets. Position yourself as an expert with internal stakeholders by using our comprehensive industry research to inform your reports, proposals and presentations. Our business information will save you money by helping you make better decisions, faster.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Brand Name Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Brand Name Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Brand Name Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear